$4,532.80 travel Payment -- Biogen to Dr. Brian Wright
Biogen covers travel and lodging for Internal Medicine physician in relation to Trikafta.
This page provides a detailed analysis of a $4,532.80 travel payment from Biogen to Dr. Brian Wright. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $4,532.80 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Biogen |
| Physician | Dr. Brian Wright |
| NPI Number | 1607873734 |
| Physician Specialty | Internal Medicine |
| Location | Durham, NC |
| Date of Payment | 2025-06-05 |
| Related Drug/Device | Trikafta |
| Conflict Assessment | Moderate -- Worth Noting |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Biogen made a $4.5K travel payment to Brian Wright, a Internal Medicine specialist in Durham, NC. The payment was associated with Trikafta. Biogen paid $4,532.80 for travel and lodging expenses to Dr. Brian Wright. The payment was associated with the drug Trikafta. This payment occurred on June 5, 2025, in Durham, NC.
Patient Guidance: What This Payment Means for You
This payment may cover travel and lodging expenses related to professional activities involving Trikafta. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Travel and lodging payments are common in Internal Medicine, especially for educational events or consultations related to specific therapies like Trikafta.
Regulatory Context: Sunshine Act Requirements
Payments for travel and lodging are reportable under the Sunshine Act, provided they are not de minimis or directly related to a physician's prescribing practices.
Related Topics
This payment is related to the following healthcare transparency topics:
- biogen
- trikafta
- travel-and-lodging
- internal-medicine
- physician-payment
- cms-open-payments
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Frequently Asked Questions About This Payment
What was this $4.5K payment for?
This was a travel payment of $4.5K from Biogen to Brian Wright, categorized as "Travel and Lodging". It was associated with Trikafta. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Brian Wright accept pharmaceutical money?
Yes, Brian Wright received this $4.5K payment from Biogen. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Brian Wright's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this travel payment?
A travel payment of $4.5K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Internal Medicine?
To compare this payment against Internal Medicine averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Internal Medicine physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Brian Wright's relationship with Biogen?
The payment covers travel and lodging, indicating potential educational or informational activities. This $4.5K travel payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Internal Medicine?
The specific drug Trikafta is mentioned, suggesting a focus on a particular therapeutic area.
What should patients do after learning about this payment?
This payment may cover travel and lodging expenses related to professional activities involving Trikafta.
What else should I know about this travel payment?
The payment date is in the future, which is unusual for reported CMS Open Payments data.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.